Terrie Curran - Insider Trading & Ownership

Entity
Individual
Location
C/O Myovant Sciences Inc., 320 West 37 Th Street, 5 Th Floor, New York, New York
Summary
The estimated net worth of Terrie Curran is at least $3.93 M dollars as of June 18, 2024. Terrie Curran is the President and Chief Executive, Director of Phathom Pharmaceuticals, Inc. and owns shares of Phathom Pharmaceuticals, Inc. (PHAT) stock worth about $3.78 M. Terrie Curran is the Director of Arcutis Biotherapeutics, Inc. and owns shares of Arcutis Biotherapeutics, Inc. (ARQT) stock worth about $151 K.
All Insider Reports
All Insider Reports

Ownership of Terrie Curran

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
PHAT Phathom Pharmaceuticals, Inc. President and Chief Executive, Director $3.78 M -$154 K -3.91% Mar 22, 2024
ARQT Arcutis Biotherapeutics, Inc. Director $151 K Jun 14, 2024
MYOV Myovant Sciences Ltd. Director Mar 10, 2023

Insider Transactions Reported by Terrie Curran:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership